Browsing: Longevity

FDA clears ENV-308 for Phase 1 as Enveda doses first patient and appoints former Novo Nordisk executive to lead metabolic…

Regenerative medicine firm says new capital gives it breathing room to sharpen its placenta-derived tech aimed at aging and chronic…

Zealand Pharma partners Shanghai-based OTR Therapeutics in discovery deal focused on obesity and metabolic disease. Danish biotech Zealand Pharma has…

Prof David Allison on healthspan, nutrition and how we can overcome the challenge of testing the efficacy of longevity interventions.…

Survey finds C-suite sentiment improving, dealmaking rebounding, and hiring plans warming, even as the FDA clouds the outlook. Biotech executives…

Texas A&M study shows small, consistent physical activity can reduce dementia risk in older adults with mild cognitive impairment. A…

Sun Pharma can manufacture and export, but the Delhi High Court bars Indian sales until Novo Nordisk’s patent expires in…

With new investor backing, the company prepares a £25m Series A to move its lead tauC3 antibody into human trials.…

Targeted nutrient transport is gaining traction as DHA delivery research moves from mechanism to real-world market application. The brain is…

Researchers have investigated the reporting quality of preclinical studies’ outcomes in anti-aging research. They analyzed how study quality changed over…